Delivery Order SPE2DR25D1103-SPE2DR26FD885
- Not listed
- The Defense Logistics Agency awarded a $17,006.14 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed price contract. The award was issued on July 30, 2025, with a completion date of July 31, 2025, and represents a competitively awarded, non-set-aside contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $30,483.87 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract. The award was made on November 4, 2025, with an ultimate completion date of November 5, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $58,642.50 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract. The award, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $12,269.50 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) with a completion date of September 30, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order transaction. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $16,220.13 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) with a completion date of September 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded on a competitive basis. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,063.82 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract. The delivery order was competitively awarded without set-aside provisions and is scheduled for completion by September 26, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location, leveraging its extensive...
- The Defense Logistics Agency awarded a $18,761.49 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract type. The contract was competitively awarded with no set-aside designation and carries an ultimate completion date of July 14, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,311.38 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract. This delivery order, issued on August 20, 2025, with an ultimate completion date of August 21, 2025, represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,738.79 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed price contract structure. This non-set-aside award was executed on August 14, 2025, with an ultimate completion date of August 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,371.44 to AmerisourceBergen Drug Corp for 60-tablet supplies of Eliquis 5 mg tablets, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor in the...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FD885Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,356.82 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by November 17, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The contract supports customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a key participant in the DLA's pharmaceutical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.4k | 11/14/25 |